The last 3 years continue to see California rising as a competing biotech hub, incubating fast-growing biopharma and becoming a favored satellite site to large pharma in the West Coast. Notable developments include Moderna leasing a new campus in Seattle, Fred Hutchinson Cancer Center opened a $320m campus, and Gilead’s new research center underway.
However, lingering market volatility simply means lab operations managers within fast-growing biopharma in the West Coast need to be even more adept at business operations, as they play the critical role to the health of R&D pipeline progression and business continuity in 2024.
As part of the flagship LAFM community, the premier Lab Operations & Facility Management for Biopharma Summit provided the much-needed support for lab ops experts within mid-sized biotechs. Bringing together over 60 leaders this May in San Diego and in collaboration with Merck, BioMarin and Nanoimaging, our 2024 audience joined us to: